Evidence map›Paper›PMID 30074088›Full record

ArticleAnalytical and bioanalytical chemistry2018

Lipidomic profiling of targeted oxylipins with ultra-performance liquid chromatography-tandem mass spectrometry.

Zhi-Xin Yuan, Sharon Majchrzak-Hong, Gregory S Keyes, Michael J Iadarola, Andrew J Mannes, Christopher E Ramsden

Abstract readEvaluation Study
In one paragraph

Article in Analytical and bioanalytical chemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
4.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 74 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Zhi-Xin YuanLipid Mediators, Inflammation, and Pain Unit, Laboratory of Clinical Investigation, National Institute on Aging/NIH, Baltimore, MD, USA. yuanz2@mail.nih.gov.ORCID http://orcid.org/0000-0003-4832-0997
Sharon Majchrzak-HongSection of Nutritional Neuroscience, Laboratory of Membrane Biochemistry and Biophysics, National Institute on Alcohol Abuse and Alcoholism/NIH, Bethesda, MD, USA.
Gregory S KeyesLipid Mediators, Inflammation, and Pain Unit, Laboratory of Clinical Investigation, National Institute on Aging/NIH, Baltimore, MD, USA.
Michael J IadarolaDepartment of Perioperative Medicine, Clinical Center, NIH, Bethesda, MD, USA.
Andrew J MannesDepartment of Perioperative Medicine, Clinical Center, NIH, Bethesda, MD, USA.
Christopher E RamsdenLipid Mediators, Inflammation, and Pain Unit, Laboratory of Clinical Investigation, National Institute on Aging/NIH, Baltimore, MD, USA.
National Institute on Aging · USNational Institutes of Health Clinical Center · USNational Institute on Alcohol Abuse and Alcoholism · USUniversity of North Carolina at Chapel Hill · US

Funding

The roles of lipid mediators in inflammation, pain, and neuro-degenerationZIAAG000453 · NIA · NATIONAL INSTITUTE ON AGING · PI RAMSDEN, CHRISTOPHER · 2017 to 2025
$35.1M
Integrative And Molecular Studies Of Pain And Pain ControlZIACL090033 · CLC · CLINICAL CENTER · PI MANNES, ANDREW · 2014 to 2025
$0k
The Pain Neural TranscriptomeZIACL090035 · CLC · CLINICAL CENTER · PI MANNES, ANDREW · 2014 to 2025
$0k
Intramural NIH HHS Z99 AG999999
6 · The paper itself

Abstract

Oxylipins are bioactive mediators that play diverse roles in (patho)physiology. We developed a sensitive and selective ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) method for the simultaneous profiling of 57 targeted oxylipins derived from five major n-6 and n-3 polyunsaturated fatty acids (PUFAs) that serve as oxylipin precursors, including linoleic (LA), arachidonic (AA), alpha-linolenic (ALA), eicosapentaenoic (EPA), and docosahexaenoic (DHA) acids. The targeted oxylipin panel provides broad coverage of lipid mediators and pathway markers generated from cyclooxygenases, lipoxygenases, cytochrome P450 epoxygenases/hydroxylases, and non-enzymatic oxidation pathways. The method is based on combination of protein precipitation and solid-phase extraction (SPE) for sample preparation, followed by UPLC-MS/MS. This is the first methodology to incorporate four hydroxy-epoxy-octadecenoic acids and four keto-epoxy-octadecenoic acids into an oxylipin profiling network. The novel method achieves excellent resolution and allows in-depth analysis of isomeric and isobaric species of oxylipin extracts in biological samples. The method was quantitatively characterized in human plasma with good linearity (R = 0.990-0.999), acceptable reproducibility (relative standard deviation (RSD) < 20% for the majority of analytes), accuracy (67.8 to 129.3%) for all analytes, and recovery (66.8-121.2%) for all analytes except 5,6-EET. Ion enhancement effects for 28% of the analytes in tested concentrations were observed in plasma, but were reproducible with RSD < 17.2%. Basal levels of targeted oxylipins determined in plasma and serum are in agreement with those previously reported in literature. The method has been successfully applied in clinical and preclinical studies.

Indexed as

Chromatography, High Pressure LiquidHumansIsomerismLimit of DetectionMetabolomicsOleic AcidsOxylipinsReproducibility of ResultsTandem Mass SpectrometryOleic AcidsOxylipinsLipidomicsOxylipinsPlasmaQuantitation characteristicsUltra-performance liquid chromatography-tandem mass spectrometry

Identifiers

PMID30074088
PMCPMC6314687
OpenAlexW2886984734

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.